IMMUNE DYSREGULATION
Clinical trials for IMMUNE DYSREGULATION explained in plain language.
Never miss a new study
Get alerted when new IMMUNE DYSREGULATION trials appear
Sign up with your email to follow new studies for IMMUNE DYSREGULATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common diabetes drug calm inflammation in drug users?
Disease control Recruiting nowThis study tests whether metformin, a common diabetes drug, can lower inflammation and improve immune function in 100 adults aged 18-64 who have a history of injection drug use, with or without HIV. Participants will take metformin or a placebo for 16 weeks and have their immune …
Matched conditions: IMMUNE DYSREGULATION
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 26, 2026 09:12 UTC
-
Can calming the immune system save Children's livers?
Disease control Recruiting nowThis study tests whether two drugs that calm the immune system—high-dose steroids or a medicine called anti-thymocyte globulin—can help children with sudden, severe liver failure survive without needing a liver transplant. About 163 children aged 1 to 17 will be randomly assigned…
Matched conditions: IMMUNE DYSREGULATION
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Could a stem cell transplant fix broken immune systems?
Disease control Recruiting nowThis study tests a stem cell transplant for people aged 5 to 40 with common variable immunodeficiency (CVID) or other immune regulation disorders. The goal is to replace faulty immune cells with healthy donor cells using a gentle chemotherapy and radiation preparation. While the …
Matched conditions: IMMUNE DYSREGULATION
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Immune cell secrets could unlock better lung treatments
Knowledge-focused Recruiting nowThis study looks at how immune cells behave in lung cancer, COPD, and sarcoidosis. Researchers want to understand why some people don't respond to immunotherapy. The goal is to gather knowledge that could lead to more personalized treatments in the future. About 425 participants,…
Matched conditions: IMMUNE DYSREGULATION
Phase: NA • Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC